Topic Review
Nitric Oxide as a Therapeutic Agent against SARS-CoV-2
Nitric oxide (NO) is a key player in both the cardiopulmonary and immune systems, which has already been reported as a worthy candidate for use in the treatment of human coronavirus infections, including COVID-19, because of its antivirus activity and its beneficial effects in the treatment of clinical complications in patients. In fact, inhaled nitric oxide (iNO), as a potent vasodilator, was approved to improve oxygenation in term and near-term neonates, and has been used in clinical settings. Along with its putative antiviral affect, iNO can reduce inflammatory cell-mediated lung injury by inhibiting neutrophil activation, lowering pulmonary vascular resistance, and decreasing edema in the alveolar spaces, thus collectively enhancing ventilation/perfusion matching.
  • 250
  • 20 Dec 2023
Topic Review
IGF-1/PI3K/AKT/FOXO3 Axis in Sarcopenia
The high prevalence of sarcopenia in an aging population has an underestimated impact on quality of life by increasing the risk of falls and subsequent hospitalization. Unfortunately, the application of the major established key therapeutic—physical activity—is challenging in the immobile and injured sarcopenic patient. Consequently, novel therapeutic directions are needed. The transcription factor Forkhead-Box-Protein O3 (FOXO3) may be an option, as it and its targets have been observed to be more highly expressed in sarcopenic muscle.
  • 150
  • 20 Dec 2023
Topic Review
Non-Coding RNAs in Prostate Cancer
Chemotherapy based on taxane-class drugs is the gold standard for treating advanced stages of various oncological diseases. Drug resistance is the result of a combination of different events in the tumor cells under the influence of the drug, a comprehensive understanding of which has yet to be determined.
  • 270
  • 20 Dec 2023
Topic Review
Adipose Tissue and Physical Exercise
The study of adipose tissue has received considerable attention due to its importance not just in maintaining body energy homeostasis but also in playing a role in a number of other physiological processes. Beyond storing energy, adipose tissue is important in endocrine, immunological, and neuromodulatory functions, secreting hormones that participate in the regulation of energy homeostasis.
  • 263
  • 20 Dec 2023
Topic Review
Inflammation in Heart Failure
Chronic heart failure is a terminal point of a vast majority of cardiac or extracardiac causes affecting around 1–2% of the global population and more than 10% of the people above the age of 65. Inflammation is persistently associated with chronic diseases, contributing in many cases to the progression of disease. Even in a low inflammatory state, past studies raised the question of whether inflammation is a constant condition, or if it is, rather, triggered in different amounts, according to the phenotype of heart failure. 
  • 149
  • 20 Dec 2023
Topic Review
Myostatin and the Heart
Myostatin (growth differentiation factor 8) is a member of the transforming growth factor-β superfamily. It is secreted mostly by skeletal muscles, although small amounts of myostatin are produced by the myocardium and the adipose tissue as well. Myostatin binds to activin IIB membrane receptors to activate the downstream intracellular canonical Smad2/Smad3 pathway, and additionally acts on non-Smad (non-canonical) pathways. Studies on transgenic animals have shown that overexpression of myostatin reduces the heart mass, whereas removal of myostatin has an opposite effect. 
  • 148
  • 20 Dec 2023
Topic Review
Molecular Mechanisms of IL18 in Disease
Interleukin 18 (IL18) was originally identified as an inflammation-induced cytokine that is secreted by immune cells. An increasing number of studies have focused on its non-immunological functions, with demonstrated functions for IL18 in energy homeostasis and neural stability. IL18 is reportedly required for lipid metabolism in the liver and brown adipose tissue. Furthermore, IL18 (Il18) deficiency in mice leads to mitochondrial dysfunction in hippocampal cells, resulting in depressive-like symptoms and cognitive impairment. 
  • 341
  • 20 Dec 2023
Topic Review
Endothelial Dysfunction and Oxidative Stress Influencing Thrombosis
The leading causes of death in people with diabetes are strokes and cardiovascular disease. Significant morbidity is associated with an increased risk of thrombosis, resulting in myocardial infarction, ischaemic stroke, and peripheral vascular disease, along with the sequelae of these events, including loss of functional ability, heart failure, and amputations. While the increased platelet activity, pro-coagulability, and endothelial dysfunction directly impact this risk, the molecular mechanisms linking poor glycaemic control with increased thrombotic risk remain unclear.
  • 250
  • 19 Dec 2023
Topic Review
The Mechanisms for Bone Regeneration
The bone regeneration process has historically been studied with the repair of fracture as a unique ability of our body by restoring it to its pre-injured functions. In bone biology, homeostasis is regulated by two main cellular components: osteoblasts (bone-forming cells) and osteoclasts (bone-resorbing cells). Furthermore, various inflammatory cells and cytokines dynamically interact with these cells in bone environments, which are responsible for their repair capacity. For the bone regeneration process, previous studies have emphasized the role of osteoblasts with morphogen gradients such as bone morphogenetic proteins (BMPs).
  • 763
  • 19 Dec 2023
Topic Review
Characteristics of Mucosal Layer in Gastrointestinal Tract
The main constituents of mucus are water (90–95%), electrolytes, lipids (1–2%), and proteins. Owing to the presence of mucin, a large complex glycosylated protein, mucus can form mesh-like structured viscous gel layers on various mucosal tissues, such as the gastrointestinal (GI) tract, eyes, nose, and respiratory tract. In the GI tract, the mucus layer on the surface of the epithelial membrane can act as a smart physiological barrier not only for foreign substances with harmful potential and pathogens but also for orally dosed drugs. For effective and sufficient oral drug delivery, avoiding protective mechanisms and/or even turning barrier mechanisms should be considered. Therefore, several strategies have been developed to control the diffusive properties of drug nanoparticles within the mucus layer, including the mucopenetration and mucoadhesion of NCs.
  • 148
  • 19 Dec 2023
  • Page
  • of
  • 1349
Video Production Service